Find out more about our cookie policy
Miriam Holsten from Bayer Nordic explains why Bayer chose Finland as a location for Bayer's R&D operations
Delphine Hajaji from UCB Ventures and Dan Gilbertson from Medtronic explain what makes Finland an attractive destination for investments within health tech
Miriam Holsten from Bayer Nordic explains why investing in Finland makes sense
Get the latest news and updates about our Community
* Indicates required